This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Hye Won Park: Innovator in Cancer Treatment
Introduction
Hye Won Park is a prominent inventor based in Pyeongtaek-si, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Hye Won Park holds a patent for a method of combination therapy using an anti-C-Met antibody. This method is designed for the prevention or treatment of cancer and involves co-administering an anti-c-Met antibody or an antigen-binding fragment, along with at least one of the drugs lapatinib, regorafenib, or vemurafenib. The patent also includes a pharmaceutical composition that combines these elements for effective treatment.
Career Highlights
Hye Won Park is currently employed at Samsung Electronics Co., Ltd., where she continues to advance her research in the medical field. Her work has garnered attention for its potential impact on cancer therapies.
Collaborations
Hye Won Park collaborates with notable colleagues, including Seung Hyun Lee and Geun Woong Kim, to further enhance her research efforts.
Conclusion
Hye Won Park's innovative approach to cancer treatment exemplifies the vital role of inventors in advancing medical science. Her contributions are paving the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile